Question 1

Does Wells Fargo own SAVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 10,466 shares of SAVA (Filana Therapeutics), worth $12,454.

Question 2

How many shares of SAVA does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 10,466 shares of SAVA (Filana Therapeutics).

Question 3

What is Wells Fargo's SAVA position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's SAVA position is worth $12,454.

Question 4

Is Wells Fargo buying or selling SAVA?

Accepted Answer

In Q2 2026, Wells Fargo increased its SAVA position by 2,045 shares (+24.3%).

Question 5

When did Wells Fargo first buy SAVA?

Accepted Answer

Wells Fargo already held SAVA in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	10,466	+24.3%	$12,454	0.0%	$1.19	15
2026-Q1	Decreased	8,421	-48.4%	$14,231	0.0%	$1.69	0
2025-Q4	Decreased	16,304	-18.0%	$32,282	0.0%	$1.98	0
2025-Q3	Decreased	19,883	-15.0%	$57,859	0.0%	$2.91	0
2025-Q2	Decreased	23,383	-8.7%	$42,323	0.0%	$1.81	0
2025-Q1	Decreased	25,621	-14.6%	$38,431	0.0%	$1.50	0
2024-Q4	Increased	30,004	+15.6%	$70,810	0.0%	$2.36	17
2024-Q3	Increased	25,960	+47.9%	$764,008	0.0%	$29.43	34